This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teva Pharmaceuticals International Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Nydia Lopez: Innovator in Pharmaceutical Science
Introduction
Nydia Lopez is a prominent inventor based in San Mateo Atenco, Mexico. She has made significant contributions to the field of pharmaceutical science, particularly in the development of solid-state forms of selexipag. Her work is crucial for advancing treatment options in various medical conditions.
Latest Patents
Nydia Lopez holds 1 patent for her innovative work titled "Solid state forms of selexipag." This patent focuses on the solid-state forms IV and V of selexipag, detailing the processes for their preparation, pharmaceutical compositions, and methods of use. This advancement is expected to enhance the efficacy and stability of selexipag in therapeutic applications.
Career Highlights
Nydia is currently employed at Teva Pharmaceuticals International GmbH, where she continues to push the boundaries of pharmaceutical research. Her expertise and dedication to innovation have positioned her as a valuable asset in her field.
Collaborations
Nydia has collaborated with notable colleagues, including Ales Gavenda and Hana Kantor. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Nydia Lopez exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the development of solid-state forms of selexipag, highlight her commitment to improving healthcare solutions. Her work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
